586 related articles for article (PubMed ID: 30466468)
21. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer.
Narita Y; Kato T; Takemasa K; Sato H; Ikeda T; Harada T; Oyama S; Murakami M
J Appl Clin Med Phys; 2021 Nov; 22(11):90-98. PubMed ID: 34599856
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
[TBL] [Abstract][Full Text] [Related]
24. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
[TBL] [Abstract][Full Text] [Related]
25. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
[TBL] [Abstract][Full Text] [Related]
27. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
Arnesen MR; Rekstad BL; Stokke C; Bruheim K; Løndalen AM; Hellebust TP; Malinen E
Radiat Oncol; 2016 Mar; 11():39. PubMed ID: 26968827
[TBL] [Abstract][Full Text] [Related]
28. An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
Warren S; Partridge M; Bolsi A; Lomax AJ; Hurt C; Crosby T; Hawkins MA
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):199-207. PubMed ID: 27084641
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
[TBL] [Abstract][Full Text] [Related]
30. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
32. Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArc.
Stromberger C; Cozzi L; Budach V; Fogliata A; Ghadjar P; Wlodarczyk W; Jamil B; Raguse JD; Böttcher A; Marnitz S
Strahlenther Onkol; 2016 Apr; 192(4):232-9. PubMed ID: 26852243
[TBL] [Abstract][Full Text] [Related]
33. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
[TBL] [Abstract][Full Text] [Related]
34. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
[TBL] [Abstract][Full Text] [Related]
36. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer.
Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M
J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871
[TBL] [Abstract][Full Text] [Related]
37. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer.
Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L
Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052
[TBL] [Abstract][Full Text] [Related]
38. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
[TBL] [Abstract][Full Text] [Related]
40. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
Yeung D; McKenzie C; Indelicato DJ
Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
